Akari Therapeutics Plc: Akari Therapeutics to Participate in the Jefferies London Healthcare Conference
NEW YORK and LONDON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases